Halozyme Therapeutics
HALO
#2357
Rank
HK$59.86 B
Marketcap
HK$505.33
Share price
-1.39%
Change (1 day)
5.01%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of December 2025 : HK$1.11 Billion

According to Halozyme Therapeutics's latest financial reports the company has HK$1.11 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31HK$1.11 B-75.99%
2024-12-31HK$4.62 B76.35%
2023-12-31HK$2.62 B-7.42%
2022-12-31HK$2.83 B-50.94%
2021-12-31HK$5.77 B102.51%
2020-12-31HK$2.85 B-13.04%
2019-12-31HK$3.28 B18.17%
2018-12-31HK$2.77 B-24.27%
2017-12-31HK$3.66 B130.63%
2016-12-31HK$1.58 B89.3%
2015-12-31HK$0.83 B-20.18%
2014-12-31HK$1.05 B89.73%
2013-12-31HK$0.55 B-28.11%
2012-12-31HK$0.77 B87.98%
2011-12-31HK$0.41 B-36.68%
2010-12-31HK$0.64 B23.86%
2009-12-31HK$0.52 B6.24%
2008-12-31HK$0.49 B-35.35%
2007-12-31HK$0.76 B121.6%
2006-12-31HK$0.34 B131.69%
2005-12-31HK$0.14 B19.24%
2004-12-31HK$0.12 B3086.98%
2003-12-31HK$3.9 M414.68%
2002-12-31HK$0.75 M272.26%
2001-12-31HK$0.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
HK$157.51 B 13,975.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$106.53 B 9,419.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$56.95 B 4,988.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$77.93 B 6,864.31%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
HK$15.40 B 1,276.56%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
HK$2.03 B 82.07%๐Ÿ‡บ๐Ÿ‡ธ USA